Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study
Pharmaceuticals · 2025-03-19 · 18 (3) · 433
DOI: 10.3390/ph18030433 ↗At a glance
Journal article in Pharmaceuticals, published online on 2025-03-19. Written by Arif Jamal Siddiqui and 8 co-authors. Institution: Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia. Cited 8 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Scientific Research Deanship at University of Ha'il - Saudi Arabia, Scientific Research Deanship at the University of Ha’il—Saudi Arabia.
Abstract (original language)
Background/Objectives: The present study investigated the anticancer potential of Asparagus racemosus Willd. against triple-negative breast cancer (TNBC) using a combined in silico and in vitro approach.
Methods
Network pharmacology identified 115 potential targets shared between A. racemosus phytochemicals and TNBC, highlighting key cancer-related pathways. Molecular docking predicted strong binding affinities between specific phytochemicals (beta-sitosterol, quercetin, and others) and crucial TNBC targets, including AKT1 and ERBB2.
Results
Molecular dynamics simulations validated these interactions, demonstrating stable complex formation. In vitro, A. racemosus crude extracts exhibited potent anticancer activity against MDA-MB-231 TNBC cells, showing a dose-dependent reduction in viability (IC50 = 90.44 μg/mL), induction of G1 phase cell cycle arrest, and significant early apoptosis.
Conclusions
These integrated findings provide compelling evidence for the anticancer potential of A. racemosus against TNBC, suggesting its promise for further development as a therapeutic strategy.
Subjects
Author keywords
Authors and institutions
- Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
- Research and Development Cell (RDC), Parul University, Waghodia, Vadodara 391760, Gujarat, India.
- Department of Biotechnology, Parul Institute of Applied Sciences, Parul University, Waghodia, Vadodara 391760, Gujarat, India.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
- Department of Biophysics, University of Delhi, South Campus, New Delhi 110021, India.
ORCID profiles: Arif Jamal Siddiqui, Salem Elkahoui, Mitesh Patel, Riadh Badraoui, Mohd Adnan
Funding
- Scientific Research Deanship at University of Ha'il - Saudi Arabia
- Scientific Research Deanship at the University of Ha’il—Saudi Arabia
Cite
APA
Siddiqui, A. J., Elkahoui, S., Alshammari, A. M., Patel, M., Ghoniem, A. E. M., Abdalla, R. A. H., Dwivedi-Agnihotri, H., Badraoui, R., & Adnan, M. (2025). Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study. Pharmaceuticals, 18(3), 433. https://doi.org/10.3390/ph18030433
Vancouver
Siddiqui AJ, Elkahoui S, Alshammari AM, Patel M, Ghoniem AEM, Abdalla RAH, et al. Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study. Pharmaceuticals. 2025;18(3):433. doi:10.3390/ph18030433
BibTeX
@article{Siddiqui2025,
author = {Siddiqui, Arif Jamal and Elkahoui, Salem and Alshammari, Ahmed Mohajja and Patel, Mitesh and Ghoniem, Ahmed Eisa Mahmoud and Abdalla, Randa Abdeen Husien and Dwivedi-Agnihotri, Hemlata and Badraoui, Riadh and Adnan, Mohd},
title = {Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {3},
pages = {433},
doi = {10.3390/ph18030433}
}
EUVIMED